Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment

BACKGROUND: Anaplastic thyroid cancer (ATC) is among the most aggressive human malignancies, with a mean survival time of 6 months regardless of the treatment. METHODS: This retrospective study used the single-centre database system of the Gangnam Severance Hospital. The management and outcome data...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Haejun, Kim, Soo Young, Kim, Seok-Mo, Chang, Ho-Jin, Lee, Yong Sang, Park, Cheong Soo, Chang, Hang-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797284/
https://www.ncbi.nlm.nih.gov/pubmed/35117908
http://dx.doi.org/10.21037/tcr-20-1364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797284/
https://www.ncbi.nlm.nih.gov/pubmed/35117908
http://dx.doi.org/10.21037/tcr-20-1364

Ejemplares similares